10-121487523-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000141.5(FGFR2):c.1987-99G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.557 in 991,590 control chromosomes in the GnomAD database, including 160,533 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.47 ( 18780 hom., cov: 34)
Exomes 𝑓: 0.57 ( 141753 hom. )
Consequence
FGFR2
NM_000141.5 intron
NM_000141.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.449
Publications
9 publications found
Genes affected
FGFR2 (HGNC:3689): (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]
FGFR2 Gene-Disease associations (from GenCC):
- Apert syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- Beare-Stevenson cutis gyrata syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Genomics England PanelApp
- Crouzon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, PanelApp Australia, Genomics England PanelApp, G2P
- Jackson-Weiss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- LADD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Pfeiffer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- bent bone dysplasia syndrome 1Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- familial scaphocephaly syndrome, McGillivray typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Saethre-Chotzen syndromeInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- Antley-Bixler syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- LADD syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-121487523-C-T is Benign according to our data. Variant chr10-121487523-C-T is described in ClinVar as Benign. ClinVar VariationId is 1221003.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR2 | ENST00000358487.10 | c.1987-99G>A | intron_variant | Intron 14 of 17 | 1 | NM_000141.5 | ENSP00000351276.6 | |||
| FGFR2 | ENST00000457416.7 | c.1990-99G>A | intron_variant | Intron 14 of 17 | 1 | ENSP00000410294.2 | ||||
| FGFR2 | ENST00000369056.5 | c.1990-99G>A | intron_variant | Intron 13 of 16 | 1 | ENSP00000358052.1 | ||||
| FGFR2 | ENST00000369058.7 | c.1990-99G>A | intron_variant | Intron 14 of 16 | 1 | ENSP00000358054.3 | ||||
| FGFR2 | ENST00000613048.4 | c.1720-99G>A | intron_variant | Intron 13 of 16 | 5 | ENSP00000484154.1 | ||||
| FGFR2 | ENST00000369061.8 | c.1651-99G>A | intron_variant | Intron 11 of 14 | 1 | ENSP00000358057.4 | ||||
| FGFR2 | ENST00000369059.5 | c.1645-99G>A | intron_variant | Intron 12 of 15 | 5 | ENSP00000358055.1 | ||||
| FGFR2 | ENST00000360144.7 | c.1723-99G>A | intron_variant | Intron 13 of 16 | 2 | ENSP00000353262.3 | ||||
| FGFR2 | ENST00000478859.5 | c.1303-99G>A | intron_variant | Intron 13 of 16 | 1 | ENSP00000474011.1 | ||||
| FGFR2 | ENST00000429361.5 | c.763-99G>A | intron_variant | Intron 6 of 8 | 5 | ENSP00000404219.1 | ||||
| FGFR2 | ENST00000604236.5 | n.*1034-99G>A | intron_variant | Intron 13 of 16 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes AF: 0.466 AC: 70737AN: 151918Hom.: 18768 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
70737
AN:
151918
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.574 AC: 481593AN: 839556Hom.: 141753 AF XY: 0.576 AC XY: 250950AN XY: 435622 show subpopulations
GnomAD4 exome
AF:
AC:
481593
AN:
839556
Hom.:
AF XY:
AC XY:
250950
AN XY:
435622
show subpopulations
African (AFR)
AF:
AC:
4039
AN:
20064
American (AMR)
AF:
AC:
24052
AN:
34160
Ashkenazi Jewish (ASJ)
AF:
AC:
12898
AN:
21576
East Asian (EAS)
AF:
AC:
11280
AN:
33150
South Asian (SAS)
AF:
AC:
42159
AN:
66880
European-Finnish (FIN)
AF:
AC:
24218
AN:
48098
Middle Eastern (MID)
AF:
AC:
1733
AN:
3322
European-Non Finnish (NFE)
AF:
AC:
339746
AN:
573004
Other (OTH)
AF:
AC:
21468
AN:
39302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
10876
21753
32629
43506
54382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6532
13064
19596
26128
32660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.465 AC: 70766AN: 152034Hom.: 18780 Cov.: 34 AF XY: 0.467 AC XY: 34743AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
70766
AN:
152034
Hom.:
Cov.:
34
AF XY:
AC XY:
34743
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
8545
AN:
41510
American (AMR)
AF:
AC:
9477
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
2137
AN:
3468
East Asian (EAS)
AF:
AC:
1561
AN:
5162
South Asian (SAS)
AF:
AC:
3011
AN:
4822
European-Finnish (FIN)
AF:
AC:
5190
AN:
10566
Middle Eastern (MID)
AF:
AC:
166
AN:
292
European-Non Finnish (NFE)
AF:
AC:
39198
AN:
67928
Other (OTH)
AF:
AC:
1048
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1790
3580
5370
7160
8950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1654
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.